Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Traditional Chinese medicine composition for preventing and treating inflammatory anemia

A composition and inflammatory technology, applied in the field of biomedicine, to achieve the effect of broadening the scope of indications and achieving significant preventive and therapeutic effects

Active Publication Date: 2022-02-18
ZHUZHOU QIANJIN PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether this traditional Chinese medicine still has an effect on other types of anemia such as inflammatory anemia and how effective it is has not yet been explored by relevant research.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition for preventing and treating inflammatory anemia
  • Traditional Chinese medicine composition for preventing and treating inflammatory anemia
  • Traditional Chinese medicine composition for preventing and treating inflammatory anemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 Lipopolysaccharide-induced inflammatory anemia model experiment in mice

[0024] 1. Materials and methods:

[0025] 1. Chinese medicine prescription: Chinese medicine composition includes 100 parts of angelica, 100 parts of astragalus, 30 parts of donkey-hide gelatin, 150 parts of motherwort, and 3 parts of tangerine peel. The preparation method is as described above, and it is prepared into pills.

[0026] 2. Animals C57B6 male mice, 8 weeks old, were randomly divided into four groups according to body weight after one week of adaptive feeding, which were blank control group (CON), traditional Chinese medicine group (AA), lipopolysaccharide group (LPS), and lipopolysaccharide group (LPS). The polysaccharide was dissolved in PBS, and the lipopolysaccharide and traditional Chinese medicine group (LPS+AA), 5 rats in each group.

[0027] The mice in each group were given medicine, the blank control group was given PBS, the Chinese medicine group was administere...

Embodiment 2

[0048] Example 2 Freund's complete adjuvant-induced inflammatory anemia pharmacological and pharmacodynamic experiments in rats

[0049] 1. Experimental materials

[0050] Experimental animals: male SD rats, 150±2g, 6-8 weeks old, commercially available.

[0051] Chinese medicine prescription is the same as embodiment 1.

[0052] 2. Animal feeding and grouping

[0053]After one week of adaptive feeding, male SD rats were weighed and marked with picric acid. Five rats were fed in each cage. The bedding in the cage was replaced every two days and wiped and disinfected with 75% alcohol. The temperature of the animal room was 23±2°C, and the relative humidity was 50±20%, natural lighting. All rats were free to eat and drink, and all operations strictly followed the "Regulations on the Management of Experimental Animals".

[0054] The model was established by subcutaneously injecting 0.15 mL of Mycobacterium tuberculosis with Freund's complete adjuvant at a concentration of 10 ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of a traditional Chinese medicine composition in preparation of a medicine for preventing / treating inflammatory anemia. The traditional Chinese medicine composition comprises angelica sinensis, astragalus membranaceus, colla corii asini, leonurus japonicus and pericarpium citri reticulatae. Experimental results of influences of the formula on serum iron of normal mice and mice with inflammatory anemia show that the serum iron and iron-carrying saturation of the mice can be increased under physiological conditions; directed at an inflammatory anemia mouse model, the traditional Chinese medicine composition can inhibit decrease of serum iron and iron-carrying saturation caused by lipopolysaccharide, can significantly inhibit secretion of serum pro-inflammatory factors TNF-alpha and IL-6 of ACD rats, and can be used for preparing drugs for preventing and treating inflammatory anemia. According to the traditional Chinese medicine composition, the adaptation disease range of the composition is widened, a new traditional Chinese medicine composition choice is provided for preventing and treating the inflammatory anemia, and the traditional Chinese medicine composition has obvious application value for preventing and treating the inflammatory anemia.

Description

technical field [0001] The invention belongs to the technical field of biomedicine. More specifically, it relates to the application of a traditional Chinese medicine composition in preventing and treating inflammatory anemia. Background technique [0002] The classification and causes of anemia are relatively complicated. Inflammatory anemia (AI), also known as chronic inflammatory anemia (anemia of chronic disease, ACD), is a kind of anemia, which is manifested by decreased serum iron and transferrin saturation, and red blood cell production. The amount of available iron decreases and the production of red blood cells slows down. Chronic inflammatory anemia is mainly caused by iron metabolism disorder and abnormal iron incorporation into erythroid precursor cells. The increase of hepcidin induced by inflammatory factors is the key to chronic inflammatory anemia. For example, the levels of inflammatory cytokines IL-1, IL-6, TNF-a, and BMP in the body increase. Inflammator...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/752A61P7/06A61K35/36A61K36/232A61K36/481A61K36/533
CPCA61K36/232A61K36/481A61K35/36A61K36/533A61K36/752A61P7/06A61K2236/331A61K2236/333A61K2236/51A61K2300/00Y02A50/30
Inventor 蹇顺彭开锋张素英冯鑫颜利玲钟爱军龚云荣苑君王英
Owner ZHUZHOU QIANJIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com